Mangiferin exerts antitumor activity in breast cancer cells by regulating matrix metalloproteinases, epithelial to mesenchymal transition, and β-catenin signaling pathway. [electronic resource]
Producer: 20131112Description: 180-90 p. digitalISSN:- 1096-0333
- Animals
- Antineoplastic Agents, Phytogenic
- Apoptosis -- drug effects
- Blotting, Western
- Breast Neoplasms -- drug therapy
- Cell Line, Tumor
- Dependovirus -- genetics
- Enzyme-Linked Immunosorbent Assay
- Epithelial-Mesenchymal Transition -- drug effects
- Female
- Flow Cytometry
- Fluorescent Antibody Technique
- Gene Expression Regulation, Enzymologic -- drug effects
- Humans
- Immunohistochemistry
- Indicators and Reagents
- Matrix Metalloproteinase 7 -- biosynthesis
- Matrix Metalloproteinase 9 -- biosynthesis
- Matrix Metalloproteinases -- biosynthesis
- Mice
- Mice, Hairless
- Signal Transduction -- drug effects
- Xanthones -- pharmacology
- beta Catenin -- physiology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.